Atlas Venture Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 14
- Investments
- 729
- Portfolio
- 85
- Exits
- 341
Atlas Venture General Information
Description
Founded in 1980, Atlas Venture is a venture capital firm based in Cambridge, Massachusetts. The firm seeks to invest in the life sciences, biotechnology, and drug discovery sectors.
Contact Information
Website
Year Founded
1980
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- 300 Technology Square
- 8th Floor
- Cambridge, MA 02139
- United States
+1 (857) 000-0000
Atlas Venture Investments & Acquisitions (729)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Scorpion Therapeutics | 07-Jan-2021 | Early Stage VC | 00000 | Drug Discovery | Startup | 0000-00000000 0000000 00 |
| 00000 00000000 | 05-Jan-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | 0000-00000000 0000000 00 |
| 00000 000000000000 | 08-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 000000000 00.0 |
| 0000000 0000000000 | 30-Nov-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 000000000 00.0 |
| 00000000000 | 09-Nov-2020 | 00000 00000 | 00.00 | Entertainment Software | Generating Revenue | |
| 000 000 | 29-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000 0000000 00 |
| 00000000 000000000 | 26-Oct-2020 | 00000 00000 | 00000 | Drug Discovery | Startup | 0000-00000000 0000000 00 |
| 00 000000000 | 22-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 000000 |
| Gemini Therapeutics | 15-Oct-2020 | PIPE | 0000 | Drug Discovery | Generating Revenue | 00000 000000 |
| Vigil Neuroscience | 05-Oct-2020 | Early Stage VC | 000.00 | Other Healthcare Services | Stealth | 00000 00000 00.0 |
Atlas Venture Exits (339)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Generation Bio | 07-Jan-2021 | Public Investment 2nd Offering | 00000 |
| 000000 | 17-Dec-2020 | 0000000 000000 | |
| 0000000 000000 | 10-Dec-2020 | 000 | 00000 |
| 0-0000 00000000000 | 22-Nov-2020 | 0000000 000000 | |
| 0000000000 | 08-Oct-2020 | 000000 0000000000 | 00.000 |
| 0000 000000000000 | 17-Sep-2020 | 000 | 00000 |
| 000000 | 01-Sep-2020 | 000000000000000000 | 00000 |
| 000000 00000000000 | 21-Aug-2020 | 000 | 00000 |
| DisplayLink | 31-Jul-2020 | Merger/Acquisition | 00000 |
| Akero Therapeutics | 09-Jul-2020 | Public Investment 2nd Offering | 00000 |
Atlas Venture Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Atlas Venture‘s full profile, request access.
Request a free trialAtlas Venture Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAtlas Venture Team (131)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Rajesh Devraj Ph.D | Venture Partner | 0 | Cambridge, MA | ||
| David Grayzel MD | Partner | 0 | 0 | 0 | Cambridge, MA |
| Jason Rhodes | Partner | 00 | 0 | 0 | Cambridge, MA |
| Jean-Francois Formela MD | Partner | 00 | 00 | 00 | Cambridge, MA |
| Michael Gladstone | Partner | 0 | 0 | 0 | Cambridge, MA |
Atlas Venture Co-Investors (141)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 6 | 0 |
|
|
|
| Citadel (Hedge Fund) | 0 | 0 |
|
|
|
| Cormorant Asset Management | 0 | 0 |
|
|
|
| GV | 0 | 0 | 0 |
|
|
| OrbiMed | 0 | 0 |
|
|